Understand your options

A low-dose sublingual formulation that dissolves under the tongue. Microdosing may allow a gradual introduction for sensitive patients. Evidence specifically supporting sublingual delivery or microdosing at this scale remains limited.

A sublingual formulation delivering tirzepatide without injection. Convenient for patients who prefer a needle-free option. Comparative bioavailability data versus subcutaneous injection remain limited.

A compounded subcutaneous injection combining a lower-than-standard dose of tirzepatide with vitamin B12. May support a slower titration for sensitive patients. Evidence specifically for this combination is limited.

A compounded subcutaneous injection combining a lower-than-standard dose of tirzepatide with glycine. Some providers explore glycine for potential metabolic or sleep support, though robust evidence for this combination is lacking.

A standard-dose compounded tirzepatide injection with vitamin B12. B12 is sometimes included to support energy levels during calorie restriction. Evidence for added benefit in this specific combination is not strongly established.

A standard-dose compounded tirzepatide injection with glycine. Glycine is an amino acid sometimes added for potential metabolic support. Evidence for this specific combination remains limited.

A growth hormone-releasing hormone (GHRH) analogue that stimulates the pituitary to produce growth hormone. May support sleep quality, recovery, and lean body composition. Evidence is more limited than for FDA-approved growth hormone therapies.

A master antioxidant naturally produced in the body. Injectable glutathione is used to support oxidative stress reduction and cellular health. Evidence for clinical benefit via injection in healthy individuals remains mixed.

A synthetic peptide derived from a protein found in gastric juice. Studied in animal models for tissue repair and gut health. Human clinical trial data are limited; this is considered a research-stage compound.

A copper peptide with antioxidant and tissue-remodeling properties studied in skin and wound healing research. Injectable use in systemic wellness is less established than topical applications.

A compounded topical cream containing the copper peptide GHK-Cu. May support skin texture, firmness, and wound healing. Topical evidence is more established than systemic injectable use.

A mitochondria-derived peptide studied for potential effects on metabolic regulation, insulin sensitivity, and exercise performance. Human clinical data are early-stage and limited.

A GHRH analogue with an FDA-approved indication for HIV-associated lipodystrophy. Compounded versions used for general body composition or anti-aging purposes are not FDA-approved for those uses.

A synthetic tetrapeptide studied for potential effects on telomere length and longevity. Human clinical evidence is very limited; most data come from animal and in vitro studies.

A mitochondria-targeting peptide studied for potential cardioprotective and anti-aging effects. Human clinical trial data are limited and early-stage.

A thymic peptide studied for immune modulation. Has been used in some countries for hepatitis and immune support. Evidence in general wellness contexts is limited.

A combination of two neuropeptides studied in Russia for cognitive support and anxiolytic effects. Human clinical data from Western peer-reviewed trials are very limited.

A combination of a GHRH analogue (CJC-1295) and a growth hormone secretagogue (Ipamorelin) used to stimulate growth hormone release. May support sleep, recovery, and body composition. Evidence is more limited than for approved GH therapies.

A combination of BPC-157 and TB-500 (Thymosin Beta-4 fragment), both studied for tissue repair and recovery in animal models. Human clinical data are limited for both compounds.

A three-peptide combination targeting tissue repair, recovery, and skin health. Each component has limited human clinical data; the combination has not been studied in clinical trials.

A four-peptide combination adding KPV (a melanocortin peptide with studied anti-inflammatory properties) to the Glow Stack. Clinical trial data for this combination are not available.

A melanocortin receptor agonist studied for sexual dysfunction. An FDA-approved version (bremelanotide/Vyleesi) exists for hypoactive sexual desire disorder in premenopausal women. Compounded versions are not FDA-approved.

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme involved in cellular energy metabolism. Injectable NAD+ is used to support energy, cognitive clarity, and cellular repair. Evidence from large-scale clinical trials is limited.

A lipotropic injection combining B vitamins and amino acids (such as methionine, inositol, choline) to support fat metabolism and energy. Evidence for meaningful weight loss beyond lifestyle changes is limited.

A topical serum containing minoxidil, which has FDA-approved indications for androgenetic alopecia. Compounded concentrations or formulations differ from approved products and are not FDA-approved.

Naltrexone is FDA-approved at standard doses for opioid and alcohol use disorder. Low-dose use (1–4.5 mg) for immune modulation, pain, and inflammation is off-label and not FDA-approved at those doses. Evidence is growing but not yet definitive.

A compounded topical estradiol cream applied to the skin to help relieve menopausal symptoms such as hot flashes, night sweats, and sleep disturbances. Compounded versions differ from FDA-approved topical estradiol products.

A low-dose vaginal estradiol cream that may help relieve vaginal dryness, discomfort, and urinary symptoms associated with menopause. Compounded versions differ from FDA-approved vaginal estradiol products.

Transdermal estradiol patches deliver a consistent dose of estradiol through the skin. Currently out of stock due to a nationwide shortage.

Oral micronized progesterone is often prescribed alongside estrogen therapy to protect the uterine lining. May also support sleep and mood. Compounded versions differ from FDA-approved oral progesterone (Prometrium).

A low-dose topical testosterone gel for women to support libido, energy, and overall wellbeing. No testosterone product is currently FDA-approved specifically for women; use is off-label. Requires recent lab work.

A low-dose testosterone injection for women to support libido, energy, and wellbeing. Off-label use; no testosterone product is FDA-approved specifically for women. Requires recent lab work.

Testosterone replacement therapy, enclomiphene, and hCG care for men is handled by Scoreboard Health, our dedicated men's telehealth brand operated by Clarity Health LLC.

Botulinum toxin type A (Botox) is an FDA-approved neuromodulator that temporarily relaxes targeted facial muscles to soften dynamic wrinkles — including forehead lines, frown lines between the brows, and crow's feet. Results typically last 3–4 months. Treatment takes 10–15 minutes with no downtime.

Dysport is an FDA-approved abobotulinumtoxinA neuromodulator used to treat moderate to severe glabellar lines (frown lines between the brows). It has a slightly faster onset than Botox and may spread more diffusely, making it well-suited for larger treatment areas. Results typically last 3–4 months.

Xeomin is an FDA-approved incobotulinumtoxinA neuromodulator that contains only the active toxin without accessory proteins. This 'naked' formulation may reduce the risk of antibody formation with repeated use. It is used to treat glabellar lines and other dynamic facial wrinkles. Results typically last 3–4 months.

Hyaluronic acid dermal fillers (such as Juvederm and Restylane product lines) are used to add volume, define contours, and smooth lines in the lips and face. Common treatment areas include lips, nasolabial folds, marionette lines, cheeks, and under-eye hollows. Results typically last 6–18 months depending on the product and area treated.

Sculptra (poly-L-lactic acid) is an FDA-approved collagen biostimulator that works gradually by stimulating the body's own collagen production rather than adding immediate volume. It is used to restore facial volume, improve skin texture, and address deep folds. A series of 2–3 treatment sessions is typically recommended, with results developing over several months and lasting up to 2 years.

Non-surgical hip and buttock contouring using biostimulator injections (such as Sculptra or Radiesse) to add subtle volume, improve shape, and stimulate collagen in the hip dip and gluteal areas. This is a non-surgical alternative to implants or fat transfer, with results developing gradually over several months. A series of treatment sessions is typically required.

Zerona is an FDA-cleared low-level laser (cold laser) body contouring treatment that uses 635nm laser energy to emulsify fat within adipocytes, allowing the contents to be naturally eliminated by the lymphatic system. It is non-invasive, painless, and requires no downtime. A standard protocol involves 6 sessions over 2 weeks. Results are best maintained with adequate hydration and light activity during the treatment series.

Radiofrequency (RF) and body sculpting devices use controlled energy — including RF, electromagnetic stimulation, or ultrasound — to target subcutaneous fat, tighten skin, and improve body contour. Common platforms include RF skin tightening and high-intensity focused electromagnetic (HIFEM) muscle stimulation. Treatment areas include abdomen, flanks, thighs, arms, and buttocks. Multiple sessions are typically recommended for optimal results.

Our clinic offers additional non-invasive body contouring modalities based on individual goals and provider assessment. These may include cryolipolysis (fat freezing), ultrasound cavitation, or combination protocols. Your provider will recommend the most appropriate approach following a body composition evaluation and discussion of your goals.

Medical-grade facials and Hydrafacial-type treatments combine deep cleansing, exfoliation, extraction, and hydration in a single session. These multi-step treatments address congestion, uneven texture, dullness, and dehydration. Suitable for most skin types with no downtime. Results are visible immediately and improve with a series of treatments.

Superficial chemical peels use alpha-hydroxy acids (AHAs), beta-hydroxy acids (BHAs), or low-concentration trichloroacetic acid (TCA) to exfoliate the outermost layer of skin. They address mild hyperpigmentation, uneven texture, fine lines, and acne-prone skin. Minimal downtime — mild flaking for 2–5 days is common. A series of peels is typically recommended for best results.

Microdermabrasion is a non-chemical mechanical exfoliation treatment that uses a diamond-tip or crystal-based handpiece to remove dead skin cells and stimulate cell turnover. It improves skin texture, tone, and mild hyperpigmentation with no downtime. It is suitable for most skin types and can be combined with other treatments for enhanced results.

Device microneedling uses a motorized pen with fine needles to create controlled micro-channels in the skin, stimulating collagen and elastin production. It is used to address fine lines, acne scars, enlarged pores, and overall skin texture. Mild redness for 24–48 hours is expected. Performed under provider oversight where required by state scope-of-practice regulations.

Intense Pulsed Light (IPL) and light laser treatments target pigmentation, redness, broken capillaries, and sun damage using broad-spectrum or targeted light energy. IPL is effective for photorejuvenation, rosacea, and melasma management. Performed only by or under the direct supervision of a licensed provider in compliance with applicable state regulations. Sun avoidance before and after treatment is essential.